Solventum Corp
Close on Oct 19, 2026
- Market cap
- $14.74B
- P/E (TTM)
- 10.4
- Dividend yield
- –
About Solventum
Surgical & Medical Instruments & Apparatus, SIC 3841
Solventum Corporation is a global healthcare enterprise that develops, manufactures, and commercializes clinical and technological solutions. The company operates across three core business segments: MedSurg, Dental Solutions, and Health Information Systems. Its MedSurg portfolio encompasses negative pressure wound therapy, dressings, surgical supplies, and infection-prevention devices. The Dental Solutions division delivers restorative materials, cements, and orthodontic equipment covering comprehensive tooth care. Through its Health Information Systems unit, the organization supplies documentation software, automated billing and coding platforms, speech recognition, and data tools. Solventum sells its products and services directly and through partner networks to multidisciplinary hospitals, private clinics, physicians, and dental practitioners.
The company maintains a worldwide commercial presence with sales spanning more than 90 countries. Solventum employs approximately 20,000 workers across its global facilities, including roughly 10,000 staff members in the United States and about 2,000 in Germany. Around 4,000 team members work as production staff in international manufacturing plants. Operating through a global hub-and-spoke distribution model, the company maintains regional supply networks and worldwide production centers. The provided text does not state the city or country of its corporate headquarters.
Summary of the business section of Solventum's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Solventum Corp
- Founded
- 2024
- Headquarters
- Eagan, MN
- Address
- 1750 Yankee Doodle Road 55121
- Phone
- (651) 733-1110
- Website
- www.solventum.com
- Employees
- 10,000, Dec 31, 2025
- Industry
- Surgical & Medical Instruments & Apparatus
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- PricewaterhouseCoopers LLP, Minneapolis, Minnesota
Stock & identifiers
- Ticker
- SOLV
- Exchange
- NYSE
- Shares outstanding
- 170M, Jul 31, 2026
- Public float
- $13.10B, Jun 30, 2025
- Filer category
- Large accelerated filer
- SEC CIK
- 1964738
- CUSIP
- 83444M101
- ISIN
- US83444M1018
- LEI
- 254900I70403OSGY4M28
- EIN
- 92-2008841
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Bryan C. Hanson | Chief Executive Officer, Director | 185,515 |
| Neil Craig Zieselman | SVP, Controller & CAO | – |
| Marcela A. Kirberger | Chief Legal Affairs Officer | 15,492 |
| Tammy L. Gomez | Chief Human Resources Officer | 15,030 |
| Amy Landucci | Chief Information Officer | 39,888 |
| Wayde D. McMillan | Chief Financial Officer | 53,041 |
| Paul S. Harrington | Chief Supply Chain Officer | 20,452 |
| Mary T. Wilcox | Chief Accounting Officer | 6,904 |
| Heather Knight | Chief Commercial Officer | – |
| Chris Barry | Executive Vice President | 4,624 |
| Corp Solventum | Chief Legal Affairs Officer | 2,569 |
| Susan D. DeVore | Director | 8,947 |
| Amy McBride Wendell | Director | 10,422 |
| Shirley Ann Edwards | Director | 8,947 |
| Karen J. May | Director | 8,947 |
| Carrie Smith Cox | Director | 16,400 |
| Bernard A. Harris Jr | Director | 8,947 |
| John H. Weiland | Director | 8,947 |
| Carlos Alban | Director | 8,947 |
| Glenn A. Eisenberg | Director | 8,947 |
| Darryl L. Wilson | Director | 8,947 |
| Elizabeth Mily | Director | 9,009 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 Bryan C. Hanson | $20.14M | $40.02M | $5.07M | $115 | $109 |
| FY2024 Bryan C. Hanson | $39.96M | $40.24M | $8.53M | $96 | $95 |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Employees
Headcount reported in annual reports
“We have approximately 10,000 employees in the United States and approximately 2,000 in Germany.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Sep 2, 2025 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Nov 15, 2024 | Merger | Registration of securities for a merger or exchange offer (S-4) |
| Feb 20, 2024 | Spin-off | Registration as a new public company (Form 10), e.g. spin-off |
| Feb 9, 2024 | Name change | Name changed from 3M Health Care Co to Solventum Corp |